Amgen’s stock closes off lows to avoid worst day in 24 years as weight-loss-drug data underwhelms
Amgen Inc.’s stock closed down 4.8% Tuesday, after the company said a mid-stage trial of its weight-loss treatment MariTide ...
Weight-loss-drug makers’ stocks get a boost from new Biden coverage proposal, but will it hold up?
The stocks of companies that make the new class of drugs to treat obesity and manage diabetes were higher across the board ...